冠状动脉样硬化斑块的组成和分类在高胆固醇的猪
bioRxiv : the preprint server for biology
|July 15, 2025
概括
家庭高胆固醇血清症 (FH) 猪吃高脂肪饮食会像人类一样患上冠状动脉样硬化. 猪斑块的新分类系统揭示了与人类冠状动脉样硬化病 (CAD) 类型的相似之处.
科学领域:
- 心血管研究研究心血管研究
- 疾病的动物模型.
- 动脉样硬化病原体的产生
背景情况:
- 在高脂肪饮食 (HFD) 上的家族性高胆固醇血清症 (FH) 猪会发展出模仿人类冠状动脉样硬化病 (CAD) 的冠状动脉样硬化病变.
- 目前,猪动脉样硬化症缺乏标准化的分类系统,这阻碍了比较研究.
- FH猪为动脉样硬化研究提供了有价值的临床前模型.
研究的目的:
- 开发和验证FH猪冠状动脉样硬化的分类系统.
- 建立猪斑块形态和人类CAD病变类型之间的相关性.
- 为了强调FH猪作为CAD研究临床前模型的实用性.
主要方法:
- 从动脉样硬化FH猪中分离并对104个冠状动脉斑片段进行形态分析.
- 斑块特征的量化,包括内心介质比率,死核面积和纤维盖厚度.
- 多功能聚类,免疫组织化学和新血管化,原,化和易受损伤的斑块特征的评估.
主要成果:
- 一个多功能集群算法确定了四个不同的猪斑块组 (A-D).
- 猪斑块类型A,B,C和D被发现与人类病变类型III,IV,V和VI相对应.
- FH猪的冠状动脉样硬化谱与人类的冠状动脉样硬化谱相当,包括易受损伤的斑块特征.
结论:
- FH猪模型显示了促进冠状动脉样硬化病 (CAD) 研究的巨大潜力.
- 一个经过验证的分类系统增强了FH猪在研究动脉样硬化,特别是易受损伤的斑块方面的实用性.
- 这项研究为在CAD的临床前发现研究中利用FH猪提供了一个框架.
相关概念视频
Atherosclerosis I: Introduction
92
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
92
Coronary Artery Disease II: Pathophysiology
40
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
40
Inflammation
55.3K
Overview
55.3K
Atherosclerosis III: Management
40
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
40
Coronary Artery Disease I: Introduction
60
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
60
Cholesterol: Significance and Regulation
696
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
696


